Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung
The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystall...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US |
| description | The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE683167TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE683167TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE683167TT13</originalsourceid><addsrcrecordid>eNqNyjEKwjAUh_EsDqLeIRdwKIXqrpXuBgeXEpp_TTC-V14SRM_m5sUE8QBOHz_45upoIPbJKdCNif3DCQ8-sgSnCzl9gozWC-ir8z2kwYMmYVeuGXp8v0QnBILuICkjxkKXpZqNNiasfl0ofWjNrltj4h5psgMIud-3zbaumo0xVf3H8gH8xTp5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung</title><source>esp@cenet</source><creator>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US ; SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US ; MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US ; BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US ; PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</creator><creatorcontrib>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US ; SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US ; MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US ; BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US ; PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</creatorcontrib><description>The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride.</description><edition>6</edition><language>ger</language><subject>APPARATUS THEREFOR ; CHEMISTRY ; GENERAL METHODS OF ORGANIC CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1996</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961107&DB=EPODOC&CC=DE&NR=683167T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19961107&DB=EPODOC&CC=DE&NR=683167T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US</creatorcontrib><creatorcontrib>SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US</creatorcontrib><creatorcontrib>MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US</creatorcontrib><creatorcontrib>BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US</creatorcontrib><creatorcontrib>PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</creatorcontrib><title>Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung</title><description>The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride.</description><subject>APPARATUS THEREFOR</subject><subject>CHEMISTRY</subject><subject>GENERAL METHODS OF ORGANIC CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1996</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKwjAUh_EsDqLeIRdwKIXqrpXuBgeXEpp_TTC-V14SRM_m5sUE8QBOHz_45upoIPbJKdCNif3DCQ8-sgSnCzl9gozWC-ir8z2kwYMmYVeuGXp8v0QnBILuICkjxkKXpZqNNiasfl0ofWjNrltj4h5psgMIud-3zbaumo0xVf3H8gH8xTp5</recordid><startdate>19961107</startdate><enddate>19961107</enddate><creator>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US</creator><creator>SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US</creator><creator>MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US</creator><creator>BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US</creator><creator>PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</creator><scope>EVB</scope></search><sort><creationdate>19961107</creationdate><title>Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung</title><author>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US ; SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US ; MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US ; BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US ; PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE683167TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1996</creationdate><topic>APPARATUS THEREFOR</topic><topic>CHEMISTRY</topic><topic>GENERAL METHODS OF ORGANIC CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US</creatorcontrib><creatorcontrib>SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US</creatorcontrib><creatorcontrib>MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US</creatorcontrib><creatorcontrib>BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US</creatorcontrib><creatorcontrib>PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HENRY, RODGER F., WAUKEGAN, ILLINOIS 60085, US</au><au>SPANTON, STEPHEN G., GRAYSLAKE, ILLINOIS 60030, US</au><au>MORLEY, JAMES A., GURNEE, ILLINOIS 60031, US</au><au>BAUER, JOHN F., LAKE BLUFF, ILLINOIS 60044, US</au><au>PATEL, RAMESH R., CHICAGO, ILLINOIS 60659, US</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung</title><date>1996-11-07</date><risdate>1996</risdate><abstract>The present invention provides a non-solvated crystalline polymorph of terazosin monohydrochloride designated Form III and methods for its preparation. Also disclosed is terazosin monohydrochloride methanolate and processes for its production as well as processes for its conversion to other crystalline forms of terazosin monohydrochloride.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_DE683167TT1 |
| source | esp@cenet |
| subjects | APPARATUS THEREFOR CHEMISTRY GENERAL METHODS OF ORGANIC CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Terazosinmonohydrochlorid und Verfahren und Zwischenprodukte für seine Herstellung |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A04%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HENRY,%20RODGER%20F.,%20WAUKEGAN,%20ILLINOIS%2060085,%20US&rft.date=1996-11-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE683167TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |